Patents by Inventor Fredrik Almqvist

Fredrik Almqvist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230339973
    Abstract: Described is a compound of Formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment and/or prevention of a disease involving gram-positive bacteria.
    Type: Application
    Filed: May 7, 2021
    Publication date: October 26, 2023
    Inventors: Fredrik Almqvist, Pardeep Singh
  • Publication number: 20230233536
    Abstract: The present disclosure provides a compound of Formula I, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 9, 2022
    Publication date: July 27, 2023
    Inventors: Scott Hultgren, Jerome S. Pinkner, Michael Gordon Caparon, Ana Lidia Flores Mireles, Fredrik Almqvist, Pardeep Singh, Anders Lindgren, Aaron James Leonard Lynch
  • Publication number: 20230115208
    Abstract: Described is a composition that includes: (i) a drug against tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable salt thereof. The composition is useful in the treatment of tuberculosis.
    Type: Application
    Filed: September 14, 2022
    Publication date: April 13, 2023
    Inventors: Christina L. Stallings, Fredrik Almqvist, Kelly Flentie, James Arthur Dudley Good, Fritiof Ponten
  • Publication number: 20210401815
    Abstract: The present disclosure provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, optionally in combination with a drug against a disease involving gram-positive bacteria.
    Type: Application
    Filed: June 13, 2018
    Publication date: December 30, 2021
    Inventors: Scott Hultgren, Jerome S. Pinkner, Michael Gordon Caparon, Jr., Ana Lidia Flores Mireles, Fredrik Almqvist, Pardeep Singh, Anders Lindgren, Aaron James Leonard Lynch
  • Patent number: 11129816
    Abstract: Described is a composition that includes: (i) a drug against tuberculosis inhibiting the cytochrome b subunit of the bc1 complex, said cytochrome b subunit being encoded by the gene qcrB, in Mycobacterium tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: September 28, 2021
    Assignees: Quretech Bio AB, Washington University in St. Louis
    Inventors: Christina Leigh Stallings, Gregory Alexander Harrison, Fredrik Almqvist, Souvik Sarkar
  • Patent number: 10945999
    Abstract: The present disclosure provides a combination comprising: (i) a drug against tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable combination thereof. The combination may be used in the treatment and/or prevention of tuberculosis.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: March 16, 2021
    Assignees: QURETECH BIO AB, WASHINGTON UNIVERSITY IN SAINT LOUIS
    Inventors: Christina L. Stallings, Fredrik Almqvist, Kelly Flentie, James Arthur Dudley Good, Fritiof Ponten
  • Publication number: 20200352919
    Abstract: Described is a composition that includes: (i) a drug against tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable salt thereof. The composition is useful in the treatment of tuberculosis.
    Type: Application
    Filed: July 24, 2020
    Publication date: November 12, 2020
    Inventors: Christina L. Stallings, Fredrik Almqvist, Kelly Flentie, James Arthur Dudley Good, Fritiof Ponten
  • Publication number: 20200345707
    Abstract: Many Gram-negative pathogens assemble adhesive pili structures on their surfaces that allow them to colonize host tissues and cause disease. The present invention relates to novel compounds that disrupt the intramolecular interactions of the pilus subunits thereby reducing pilus assembly.
    Type: Application
    Filed: January 27, 2020
    Publication date: November 5, 2020
    Inventors: Scott HULTGREN, Natalie OMATTAGE, Fredrik ALMQVIST, Jerome PINKNER, Karen DODSON, Peng YUAN
  • Publication number: 20200316036
    Abstract: Described is a composition that includes: (i) a drug against tuberculosis inhibiting the cytochrome b subunit of the bc1 complex, said cytochrome b subunit being encoded by the gene qcrB, in Mycobacterium tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 5, 2018
    Publication date: October 8, 2020
    Inventors: Christina Leigh Stallings, Gregory Alexander Harrison, Fredrik Almqvist, Souvik Sarkar
  • Patent number: 10294244
    Abstract: The disclosure relates to certain novel substituted ring-fused thiazolino 2-pyridines of Formula I, to processes for preparing such compounds, to their use in treating a bacterial infection such as Chlamydia infection, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: May 21, 2019
    Assignee: QURETECH BIO AB
    Inventors: James Arthur Dudley Good, Anna Martina Kulén, Klas Fredrik Almqvist, Andrew Gerard Cairns, John Fritiof Pontén
  • Publication number: 20190091210
    Abstract: The present disclosure provides a combination comprising: (i) a drug against tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable combination thereof. The combination may be used in the treatment and/or prevention of tuberculosis.
    Type: Application
    Filed: April 7, 2017
    Publication date: March 28, 2019
    Inventors: Christina L. Stallings, Fredrik Almqvist, Kelly Flentie, James Arthur Dudley Good, Fritiof Ponten
  • Publication number: 20170334931
    Abstract: The disclosure relates to certain novel substituted ring-fused thiazolino 2-pyridines of Formula I, to processes for preparing such compounds, to their use in treating a bacterial infection such as Chlamydia infection, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Application
    Filed: November 13, 2015
    Publication date: November 23, 2017
    Inventors: James Arthur Dudley Good, Anna Martina Kulén, Klas Fredrik Almqvist, Andrew Gerard Cairns, John Fritiof Pontén
  • Publication number: 20170233409
    Abstract: Described are compounds, compositions, and methods for treating or preventing conditions or disorders caused by or associated with bacterial type IV secretion systems.
    Type: Application
    Filed: February 17, 2017
    Publication date: August 17, 2017
    Inventors: Maria Hadjifrangiskou, Fredrik Almqvist, Carrie L. Shaffer, James Good
  • Patent number: 9333479
    Abstract: A device is provided for performing chemical transformation in a fluid, with a flow distributor having at least one fluid medium inlet, at least one fluid medium outlet, and at least one confinement wherein the chemical transformation is performed; and a means for rotating, rocking, wagging, or oscillating the device. At least one confinement may be equipped with a provision for providing heat, cooling, sound, light or other types of radiation, such provision being contacted to an external source through an actuator shaft. The flow distributor may be provided with sectors connected with the centrally located fluid medium inlet and a designated peripheral fluid medium outlet. The means for rotating, rocking, wagging, or oscillating the device may be an element producing magnetic fields or a shaft mechanically connected to an external actuating device.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: May 10, 2016
    Assignee: NORDIC CHEMQUEST AB
    Inventors: Jonas Persson, Kjell Oberg, Fredrik Almqvist, Knut Irgum
  • Patent number: 9056013
    Abstract: A set of femoral implants for a knee prosthesis includes at least two femoral implants having different dimensions from each other. Each femoral implant includes an outer face suitable for cooperating with one of a patellar implant and a patella of a patient, an inner face provided with an anchoring feature for anchoring to a bone of the patient, as well as a distal part and an anterior part each defined both on the outer face and the inner face. The set is characterized in that at least the distal parts of the femoral implants are substantially identical irrespective of the dimensions of the femoral implants.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: June 16, 2015
    Assignee: Tornier
    Inventors: Eric Faure, Nicolas Goubet, David Dejour, Spike Erasmus, Elizabeth Arendt, Julian Feller, Fredrik Almqvist
  • Publication number: 20140322093
    Abstract: A device is provided for performing chemical transformation in a fluid, with a flow distributor having at least one fluid medium inlet, at least one fluid medium outlet, and at least one confinement wherein the chemical transformation is performed; and a means for rotating, rocking, wagging, or oscillating the device. At least one confinement may be equipped with a provision for providing heat, cooling, sound, light or other types of radiation, such provision being contacted to an external source through an actuator shaft. The flow distributor may be provided with sectors connected with the centrally located fluid medium inlet and a designated peripheral fluid medium outlet. The means for rotating, rocking, wagging, or oscillating the device may be an element producing magnetic fields or a shaft mechanically connected to an external actuating device.
    Type: Application
    Filed: July 9, 2014
    Publication date: October 30, 2014
    Applicant: NORDIC CHEMQUEST AB
    Inventors: Jonas PERSSON, Kjell OBERG, Fredrik ALMQVIST, Knut IRGUM
  • Patent number: 8808636
    Abstract: A device is provided for performing chemical transformation in a fluid, with a flow distributor having at least one fluid medium inlet, at least one fluid medium outlet, and at least one confinement wherein the chemical transformation is performed; and a means for rotating, rocking, wagging, or oscillating the device. At least one confinement may be equipped with a provision for providing heat, cooling, sound, light or other types of radiation, such provision being contacted to an external source through an actuator shaft. The flow distributor may be provided with sectors connected with the centrally located fluid medium inlet and a designated peripheral, fluid medium outlet. The means for rotating, rocking, wagging, or oscillating the device may be an element producing magnetic fields or a shall mechanically connected to an external actuating device.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: August 19, 2014
    Assignee: Nordic Chemquest AB
    Inventors: Jonas Persson, Kjell Oberg, Fredrik Almqvist, Knut Irgum
  • Publication number: 20140121780
    Abstract: A set of femoral implants for a knee prosthesis includes at least two femoral implants having different dimensions from each other. Each femoral implant includes an outer face suitable for cooperating with one of a patellar implant and a patella of a patient, an inner face provided with an anchoring feature for anchoring to a bone of the patient, as well as a distal part and an anterior part each defined both on the outer face and the inner face. The set is characterized in that at least the distal parts of the femoral implants are substantially identical irrespective of the dimensions of the femoral implants.
    Type: Application
    Filed: June 20, 2013
    Publication date: May 1, 2014
    Inventors: Eric FAURE, Nicolas GOUBET, David DEJOUR, Spike ERASMUS, Elizabeth ARENDT, Julian FELLER, Fredrik ALMQVIST
  • Patent number: 8598195
    Abstract: The present invention relates to new compounds of the formula (I), (II), or (III) wherein R1, R2, R3, R4, R5 and W are as defined herein, and pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially A? amyloid disease, such as observed in Alzheimer's disease, infectious diseases, PAI-I related disease, and in the manufacture of medicaments for such treatment.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: December 3, 2013
    Inventors: Fredrik Almqvist, Magnus Sellstedt, Pralay Das
  • Publication number: 20130240042
    Abstract: A device is provided for performing chemical transformation in a fluid, with a flow distributor having at least one fluid medium inlet, at least one fluid medium outlet, and at least one confinement wherein the chemical transformation is performed; and a means for rotating, rocking, wagging, or oscillating the device. At least one confinement may be equipped with a provision for providing heat, cooling, sound, light or other types of radiation, such provision being contacted to an external source through an actuator shaft. The flow distributor may be provided with sectors connected with the centrally located fluid medium inlet and a designated peripheral, fluid medium outlet. The means for rotating, rocking, wagging, or oscillating the device may be an element producing magnetic fields or a shall mechanically connected to an external actuating device.
    Type: Application
    Filed: May 3, 2013
    Publication date: September 19, 2013
    Inventors: Jonas Persson, Kjell Öberg, Fredrik Almqvist, Knut Irgum